Andrea T. Hooper
Pfizer (United States)(US)Regeneron (United States)(US)Progenics Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, CAR-T cell therapy research, Angiogenesis and VEGF in Cancer
Most-Cited Works
- → REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19(2020)1,786 cited
- → Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1(2002)1,057 cited
- → CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors(2008)889 cited
- Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.(1999)
- → Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells(2010)659 cited
- → Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes(2006)637 cited